Literature DB >> 22934291

Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy.

A C Spyropoulos1, J D Douketis, G Gerotziafas, S Kaatz, T L Ortel, S Schulman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22934291     DOI： 10.1111/j.1538-7836.2012.04630.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  16 in total

Review 1.  Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

Review 2.  [Perioperative management of anticoagulation].

Authors:  R Eisele; N Melzer; P Bramlage
Journal:  Chirurg       Date:  2014-06       Impact factor: 0.955

3.  Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience.

Authors:  A Moruf; A C Spyropoulos; T Q Schardt; E Gibson; M J Manco-Johnson; M Wang; N A Goldenberg
Journal:  Thromb Res       Date:  2012-06-29       Impact factor: 3.944

Review 4.  [Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].

Authors:  S M Schellong; H Riess; M Spannagl; H Omran; M Schwarzbach; F Langer; W Gogarten; P Bramlage; R M Bauersachs
Journal:  Internist (Berl)       Date:  2018-07       Impact factor: 0.743

Review 5.  [Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].

Authors:  S M Schellong; H Riess; M Spannagl; H Omran; M Schwarzbach; F Langer; W Gogarten; P Bramlage; R M Bauersachs
Journal:  Anaesthesist       Date:  2018-08       Impact factor: 1.041

6.  Gastrointestinal endoscopy in patients receiving novel direct oral anticoagulants: results from the prospective Dresden NOAC registry.

Authors:  Vera Heublein; Sven Pannach; Katharina Daschkow; Luise Tittl; Jan Beyer-Westendorf
Journal:  J Gastroenterol       Date:  2017-05-10       Impact factor: 7.527

Review 7.  [Anticoagulation].

Authors:  B Pötzsch
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-05       Impact factor: 0.840

8.  A bridge too far? Findings of bridging anticoagulation use and outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Authors:  Amir Y Shaikh; David D McManus
Journal:  Circulation       Date:  2014-12-12       Impact factor: 29.690

9.  Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF).

Authors:  Matthew W Sherwood; James D Douketis; Manesh R Patel; Jonathan P Piccini; Anne S Hellkamp; Yuliya Lokhnygina; Alex C Spyropoulos; Graeme J Hankey; Daniel E Singer; Christopher C Nessel; Kenneth W Mahaffey; Keith A A Fox; Robert M Califf; Richard C Becker
Journal:  Circulation       Date:  2014-02-19       Impact factor: 29.690

Review 10.  [Platelet aggregation inhibitors and anticoagulants during ophthalmic interventions].

Authors:  N Feltgen; H Hoerauf; W Noske; A Hager; J Koscielny
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.